A six color flow cytometry panel and the indicated gating strategy was used to assess the percentage of CD56BrightCD3− and CD56DimCD3− NK cells producing IFNγ in 11 healthy donors and nine cancer patients (Figure 5A). This evidence concerns the gene IFNG and cancer.